The Board of Directors ofLoomis AB has resolved to repurchase shares by virtue of the authorization granted by the Annual General Meeting 2025. The repurchase may commence on November 3, 2025, end not later than on January 2, 2026, and comprise an amount up to a maximum of SEK 200 million. Repurchase shall be made […]
(TSX-V:XGC), VANCOUVER, British Columbia, Oct. 30, 2025 (GLOBE NEWSWIRE) — Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the “Company”) announces that certain directors, officers, employees and consultants of the Company have been granted incentive stock options to purchase 2,200,000 common shares of Xali Gold at an exercise price equal to $0.05 per share. The options
Tax Preparation Company Seeking 15,000 Seasonal Employees As the 2025-2026 tax season approaches, Jackson Hewitt is preparing for a surge in demand for tax preparation services due to the recently implemented tax law changes. With tax returns becoming increasingly more complex, Jackson Hewitt's seasonal staff will play a critical role in assisting clients navigate new
Xali Gold Announces Stock Options Grant GlobeNewswire October 30, 2025 VANCOUVER, British Columbia, Oct. 30, 2025 (GLOBE NEWSWIRE) — Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the “Company”) announces that certain directors, officers, employees and consultants of the Company have been granted incentive stock options to purchase 2,200,000 common shares of Xali Gold at an
NEW YORK, NY / ACCESS Newswire / October 30, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who ownâ?¯Guess Inc. ("GES" or the "Company") (NYSE:GES) stockâ?¯purchased prior to August 19, 2025. You are hereby notifiedâ?¯that Levi & Korsinsky, LLP has commenced anâ?¯investigationâ?¯into theâ?¯fairness of the
NEW YORK CITY, NY / ACCESS Newswire / October 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc.("Organogenesis" or the "Company") (NASDAQ:ORGO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Organogenesis and certain of its officers and/or directors
Young leader brings a fresh perspective and policy expertise to the forefront of compounding pharmacy advocacy RevelationPharma, a leading national network of 503A and 503B compounding pharmacies, proudly announces that Katie Johnston, Government Affairs Associate, has been elected to the Alliance for Pharmacy Compounding (APC) Board of Directors, representing the 4th District. In her role
“We wanted to create an improved helmet that would allow a motorcycle rider to signal when braking and turning,” said one of two inventors, from Los Angeles, Calif., “so we invented the HALO HELMET. Our helmet design would attract instant attention, and it would provide added protection and peace of mind for safety-conscious motorcyclists.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg
NEW YORK, NY / ACCESS Newswire / October 30, 2025 / If you suffered a loss on your Fortinet, Inc. (NASDAQ:FTNT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortinet-inc-lawsuit-submission-form?prid=174774&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
(NASDAQ:NKTX), SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conferences next month: Stifel 2025 Healthcare ConferenceNovember 12, 202510:40 a.m. ET – fireside chat TD Cowen's Immunology & Inflammation SummitNovember 13,